GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » 3-Year RORE %

Fresenius SE KGaA (Fresenius SE KGaA) 3-Year RORE % : -219.82% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Fresenius SE KGaA's 3-Year RORE % for the quarter that ended in Dec. 2023 was -219.82%.

The industry rank for Fresenius SE KGaA's 3-Year RORE % or its related term are showing as below:

FSNUY's 3-Year RORE % is ranked worse than
97.11% of 588 companies
in the Healthcare Providers & Services industry
Industry Median: 1.105 vs FSNUY: -219.82

Fresenius SE KGaA 3-Year RORE % Historical Data

The historical data trend for Fresenius SE KGaA's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA 3-Year RORE % Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 -8.26 0.83 -13.71 -219.82

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.71 -17.04 -37.34 -73.25 -219.82

Competitive Comparison of Fresenius SE KGaA's 3-Year RORE %

For the Medical Care Facilities subindustry, Fresenius SE KGaA's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's 3-Year RORE % falls into.



Fresenius SE KGaA 3-Year RORE % Calculation

Fresenius SE KGaA's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.285-0.957 )/( 1.316-0.751 )
=-1.242/0.565
=-219.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


Fresenius SE KGaA  (OTCPK:FSNUY) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Fresenius SE KGaA 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 06-01-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 05-04-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran 04-13-2021

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 05-04-2021